OrbiMed’s KalVista Pharmaceuticals KALV Stock Holding History

OrbiMed’s Portfolio KALV Stock Details KALV Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell
2022 Q3	$15.1K	Buy
2022 Q2	$1.82K	Buy
2020 Q2	–	Sell
2020 Q1	$3.22M	Buy
2019 Q4	$2.86M	Buy
2019 Q3	$449K	Buy
2019 Q2	–	Sell
2019 Q1	$2.59M	Buy